Related Experiment Videos

p16INK4 mutations and altered expression in human tumors and cell lines

A Okamoto¹, D J Demetrick, E A Spillare

¹Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Cold Spring Harbor Symposia on Quantitative Biology

|January 1, 1994

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Investigating the timing and site of recurrence for ovarian clear cell carcinoma: Analysis of the JGOG/GCIG trial-JGOG 3017-A3.

Gynecologic oncology·2024

Formulation of energy loss in a four-way circular manhole at crossroad.

Water science and technology : a journal of the International Association on Water Pollution Research·2022

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS).

Gynecologic oncology·2019

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Hydroxyapatite: catalyst for a one-pot pentose formation.

Organic & biomolecular chemistry·2017

See all related articles